SAMANTHA BRAUN: Open Payments
NPI 1013636380 · BLUE ASH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,567 in 62 payments from 23 companies in 2025. Trend: 2023 $238 · 2024 $2,056 · 2025 $1,567
Food & beverage: $1,483Education: $84
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $198 |
| Novartis Pharmaceuticals Corporation | 10 | $171 |
| E.R. Squibb & Sons, L.L.C. | 3 | $153 |
| ABBVIE INC. | 7 | $152 |
| Janssen Biotech, Inc. | 6 | $145 |
| Merck Sharp & Dohme LLC | 5 | $122 |
| Pharmacosmos Therapeutics Inc. | 1 | $108 |
| Gilead Sciences, Inc. | 5 | $105 |
| Aveo Pharmaceuticals, Inc. | 2 | $59 |
| Daiichi Sankyo Inc. | 2 | $47 |
Products named: OPDIVO, RYBREVANT, KEYTRUDA, MONOFERRIC, KISQALI, EPKINLY, Trodelvy, IMBRUVICA.
Industry payments across OH — which companies pay providers there.
